BIONTECH
BioNTech is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. The company exploits a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. Based on its deep expertise in mRNA vaccine development and in-house manufacturing capabilities, BioNTech and its collaborators are developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline.
BIONTECH
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2008-01-01
Address:
Mainz, Rheinland-Pfalz, Germany
Country:
Germany
Website Url:
http://www.biontech.de
Total Employee:
1001+
Status:
Active
Contact:
+49 6131 90-840
Email Addresses:
[email protected]
Total Funding:
1.74 B USD
Technology used in webpage:
SPF Domain Not Resolving Mobile Non Scaleable Content Amazon Organization Schema IPv6 ReCAPTCHA JsDelivr Cloudflare JS US Privacy User Signal Mechanism
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-11-09 | PhagoMed | PhagoMed acquired by BioNTech | N/A |
| 2021-07-19 | Kite - TCR therapy | Kite - TCR therapy acquired by BioNTech | N/A |
| 2020-01-16 | Neon Therapeutics | Neon Therapeutics acquired by BioNTech | 67 M USD |
Investors List
German Federal Ministry of Education and Research (BMBF)
German Federal Ministry of Education and Research (BMBF) investment in Grant - BioNTech
Temasek Holdings
Temasek Holdings investment in Post-IPO Equity - BioNTech
European Investment Bank
European Investment Bank investment in Post-IPO Debt - BioNTech
European Investment Bank
European Investment Bank investment in Post-IPO Debt - BioNTech
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Venture Round - BioNTech
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series B - BioNTech
Platinum Asset Management
Platinum Asset Management investment in Series B - BioNTech
MiraeAsset Financial Group
MiraeAsset Financial Group investment in Series B - BioNTech
Jebsen Capital
Jebsen Capital investment in Series B - BioNTech
Invus
Invus investment in Series B - BioNTech
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-02-02 | MediGene | BioNTech investment in Post-IPO Equity - MediGene | 26 M EUR |
| 2022-01-25 | InstaDeep | BioNTech investment in Series B - InstaDeep | 100 M USD |
Official Site Inspections
http://www.biontech.de Semrush global rank: 291.45 K Semrush visits lastest month: 228.31 K
- Host name: a23-48-203-103.deploy.static.akamaitechnologies.com
- IP address: 23.48.203.103
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "BioNTech"
BioNTech - Wikipedia
BioNTech was founded in 2008 based on research by UÄŸur Åžahin, Özlem Türeci, and Christoph Huber, with a seed investment of €150 million from MIG Capital, a Munich-based venture capital firm, and AT Impf, an investment vehicle under control of the single family office of German billionaire twin brothers, Andreas and Thomas Strüngmann. The company's activities focus on the development and production of technologies and drugs for individualized cancer immunotherapy. …See details»
BioNTech | Our mission: basic research in mRNA …
BioNTech’s portfolio contains more than 25 product candidates in clinical trials. In pursuit of changing the treatment paradigm with individualized cancer therapies, our pipeline encompasses oncology product candidates including …See details»
From Discovery to Delivery – Meet our Senior Team - BioNTech
Prior to joining BioNTech, she built and led a global shared services organization at Merck …See details»
Org Chart BioNTech - The Official Board
The organizational chart of BioNTech displays its 50 main executives including Ugur Sahin, Jens Holstein and Sierk Poetting. Toggle navigation The Official Board. Search. Search. Search by segment. ... BioNTech www.biontech.de. …See details»
Management Report on the Group and the Company for the 2020 …
May 19, 2021 BioNTech SE was founded in 2008 as a spin-off from the Johannes Gutenberg …See details»
BioNTech - Crunchbase Company Profile & Funding
Organization. BioNTech . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. BioNTech is a biopharmaceutical company that develops cancer therapeutics for infectious …See details»
Inside the hunt for a Covid-19 vaccine: how BioNTech …
Nov 13, 2020 By the time the World Health Organization declared a global pandemic in early March, the company had 20 mRNA candidates in development. Days later, it had signed deals with Pfizer and China’s ...See details»
Welcome to our investor page | BioNTech
Biopharmaceutical New Technologies, or BioNTech, is a global, fully integrated next-generation immunotherapy company pioneering novel therapies for cancer, infectious diseases and other serious diseases. We exploit a wide array of …See details»
Pfizer and BioNTech Announce Further Details on Collaboration to ...
Pfizer and BioNTech to jointly develop COVID-19 vaccine, initially in the United States and …See details»
BioNTech
Bei BioNTech arbeiten Unser Auftrag ist klar: Wir wollen wissenschaftliche Erkenntnisse in die Praxis umsetzen, um die Gesundheit von Menschen weltweit zu verbessern. Hierbei sind wir immer auf der Suche nach engagierten und …See details»
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron …
Jun 27, 2024 Side effects can be reported to EudraVigilance or directly to BioNTech using …See details»
The Pfizer BioNTech (BNT162b2) COVID-19 vaccine: What you …
Aug 18, 2022 The Pfizer BioNTech vaccine against COVID-19 has very high efficacy against …See details»
BioNTech and Pfizer announce regulatory approval from German …
Apr 22, 2020 MAINZ, Germany and NEW YORK, April 22, 2020 (GLOBE NEWSWIRE) -- …See details»
BioNTech | The BioNTech Board
James Ryan and his teams played a pivotal role in the successful development of the Pfizer …See details»
Pfizer–BioNTech COVID-19 vaccine - Wikipedia
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2] [33] is an …See details»
BioNTech Announces First Quarter Financial Results and Corporate …
May 9, 2022 First quarter revenues of €6.4 billion 1, net income of €3.7 billion and fully diluted …See details»
Shot of a Lifetime: How Pfizer and BioNTech Developed and …
Oct 15, 2021 On March 11, 2020 the World Health Organization declared COVID-19 a …See details»
All BioNTech locations at a glance
BioNTech SE An der Goldgrube 12 55131 Mainz, Germany. T: +49 6131 9084-0 F: +49 6131 …See details»
Rede von Außenministerin Baerbock bei der Eröffnung der …
Rede von Außenministerin Baerbock bei der Eröffnung der BioNTech-Produktionsstätte in …See details»
Real-World Evidence Confirms High Effectiveness of Pfizer …
Mar 11, 2021 Findings from the analysis were derived from de-identified aggregate Israel …See details»